SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-16-005091
Filing Date
2016-03-15
Accepted
2016-03-15 17:04:30
Documents
72
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cocp10k_dec312015.htm 10-K 1428868
2 SECURITY PURCHASE AGREEMENT ex10-1.htm EX-10.1 58784
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER (302) ex31-1.htm EX-31.1 11769
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (302) ex31-2.htm EX-31.2 11514
5 CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER (906) ex32-1.htm EX-32.1 11122
  Complete submission text file 0001415889-16-005091.txt   4836563

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cocp-20151231.xml EX-101.INS 781560
7 XBRL TAXONOMY EXTENSION SCHEMA cocp-20151231.xsd EX-101.SCH 51352
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cocp-20151231_cal.xml EX-101.CAL 51052
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cocp-20151231_def.xml EX-101.DEF 100542
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cocp-20151231_lab.xml EX-101.LAB 354982
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cocp-20151231_pre.xml EX-101.PRE 240064
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55158 | Film No.: 161507681
SIC: 2834 Pharmaceutical Preparations